文献速递流行病学与生物统计组学、生物样本库与精准医学

荷兰SARS-CoV-2全基因组测序与公共卫生决策

Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands.
PubMed 文献 · Nat Med · 2020-07-16

该研究描述荷兰首例SARS-CoV-2病例于2月27日报告后,通过近实时全基因组测序结合流行病学数据,评估社区传播范围并支持早期防控决策。疫情由来自意大利、奥地利、德国和法国的多个输入事件引发,随后在荷兰南部及以外地区出现本地扩增。

要点

  • 全基因组测序结合流行病学可近实时评估SARS-CoV-2社区传播范围。
  • 荷兰疫情由多个欧洲输入事件引发,随后出现本地扩增。
  • 测序数据支持早期公共卫生决策以控制本地传播。

核心结论

  • 全基因组测序与流行病学结合可可靠评估SARS-CoV-2社区传播范围,促进荷兰早期防控决策。

研究设计与样本

  • 研究描述荷兰SARS-CoV-2疫情中近实时全基因组测序数据的生成与分析,并结合流行病学数据。

主要发现

  • 荷兰首例SARS-CoV-2于2月27日报告,疫情由来自意大利、奥地利、德国和法国的多个输入事件引发。
  • 随后在荷兰南部及以外地区出现本地扩增。

临床怎么用

  • 利用全基因组测序结合流行病学数据近实时评估传播范围,支持早期公共卫生决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In late December 2019, a cluster of cases of pneumonia of unknown etiology were reported linked to a market in Wuhan, China1. The causative agent was identified as the species Severe acute respiratory syndrome-related coronavirus and was named SARS-CoV-2 (ref. 2). By 16 April the virus had spread to 185 different countries, infected over 2,000,000 people and resulted in over 130,000 deaths3. In the Netherlands, the first case of SARS-CoV-2 was notified on 27 February. The outbreak started with several different introductory events from Italy, Austria, Germany and France followed by local amplification in, and later also outside, the south of the Netherlands. The combination of near to real-time whole-genome sequence analysis and epidemiology resulted in reliable assessments of the extent of SARS-CoV-2 transmission in the community, facilitating early decision-making to control local transmission of SARS-CoV-2 in the Netherlands. We demonstrate how these data were generated and analyzed, and how SARS-CoV-2 whole-genome sequencing, in combination with epidemiological data, was used to inform public health decision-making in the Netherlands.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Oude Munnink BB, Nieuwenhuijse DF, Stein M, et al. Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands. Nat Med. 2020. PMID: 32678356. doi:10.1038/s41591-020-0997-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。